Literature DB >> 29424453

Clinical and genetic features of the patients with X-Linked agammaglobulinemia from Turkey: Single-centre experience.

S Esenboga1, D Cagdas1, T T Ozgur1, P Gur Cetinkaya1, L M Turkdemir1, O Sanal1, M VanDerBurg2, I Tezcan1.   

Abstract

X-linked agammaglobulinemia is a primary immunodeficiency disorder resulting from BTK gene mutations. There are many studies in the literature suggesting contradictory ideas about phenotype-genotype correlation. The aim of this study was to identify the mutations and clinical findings of patients with XLA in Turkey, to determine long-term complications related to the disease and to analyse the phenotype-genotype correlation. Thirty-two patients with XLA diagnosed between 1985 and 2016 in Pediatric Immunology Department of Hacettepe University Ihsan Dogramaci Children's Hospital were investigated. A clinical survey including clinical features of the patients was completed, and thirty-two patients from 26 different families were included in the study. Getting early diagnosis and regular assessment with imaging techniques seem to be the most important issues for improving the health status of the patients with XLA. Early molecular analysis gives chance for definitive diagnosis and genetic counselling, but not for predicting the clinical severity and prognosis.
© 2018 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Keywords:  B cells; cells; diseases; immunodeficiency; infection

Mesh:

Substances:

Year:  2018        PMID: 29424453     DOI: 10.1111/sji.12647

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication.

Authors:  Cristiane J Nunes-Santos; Christopher Koh; Anjali Rai; Keith Sacco; Beatriz E Marciano; David E Kleiner; Jamie Marko; Jenna R E Bergerson; Michael Stack; Maria M Rivera; Gregory Constantine; Warren Strober; Gulbu Uzel; Ivan J Fuss; Luigi D Notarangelo; Steven M Holland; Sergio D Rosenzweig; Theo Heller
Journal:  J Allergy Clin Immunol       Date:  2021-06-01       Impact factor: 10.793

2.  Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.

Authors:  Amit Rawat; Ankur Kumar Jindal; Deepti Suri; Pandiarajan Vignesh; Anju Gupta; Biman Saikia; Ranjana W Minz; Aaqib Zaffar Banday; Rahul Tyagi; Kanika Arora; Vibhu Joshi; Sanjib Mondal; Jitendra Kumar Shandilya; Madhubala Sharma; Mukesh Desai; Prasad Taur; Ambreen Pandrowala; Vijaya Gowri; Sneha Sawant-Desai; Maya Gupta; Aparna Dhondi Dalvi; Manisha Madkaikar; Amita Aggarwal; Revathi Raj; Ramya Uppuluri; Sagar Bhattad; Ananthvikas Jayaram; Harsha Prasad Lashkari; Liza Rajasekhar; Deenadayalan Munirathnam; Manas Kalra; Anuj Shukla; Ruchi Saka; Rajni Sharma; Ravinder Garg; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Pamela P Lee; Koon Wing Chan; Yu-Lung Lau; Surjit Singh
Journal:  Front Immunol       Date:  2021-01-15       Impact factor: 7.561

3.  Novel deletion mutation in Bruton's tyrosine kinase results in X-linked agammaglobulinemia: A case report.

Authors:  Xiao-Mei Hu; Ke Yuan; Hong Chen; Chun Chen; Yan-Lan Fang; Jian-Fang Zhu; Li Liang; Chun-Lin Wang
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.